The EV1000 clinical platform

The EV1000 clinical platform from Edwards Lifesciences presents the physiologic status of the patient in an intuitive and meaningful way. Designed in collaboration with and validated by clinicians, the EV1000 clinical platform offers you scalability and adaptability across acute care settings.

The EV1000 clinical platform enables you to choose the parameters needed to monitor your patients and is compatible with a number of Edwards advanced hemodynamic monitoring solutions.

EV1000 clinical platform

See the difference.

Presenting the physiologic status of the patient in an intuitive and meaningful way enables you to focus on your patient. The real-time physiology screen (both intermittent and continuous) depicts the interaction between the heart, blood, and vascular system.

Enhanced parameters tracking.

Enhanced parameter tracking can help you to track and manage key parameters and enables you to create and monitor customized protocols and facilitate compliance to Goal Directed Therapy (GDT) protocols. For additional insights, the Time-in-Target indicator represents the accumulated percentage of time a parameter has been within target range during an active tracking session.

Key parameter display.

The cockpit screen combines easy-to-read numbers with specific target ranges, parameters and alarms to clearly indicate patient status.

Visual clinical support.

Color-based indicators communicate patient status at a glance, and visual clinical support screens allow for immediate recognition and increased understanding of rapidly changing clinical situations to help clinicians make better decisions.

The EV1000 clinical platform product specifications

Monitor
Weight 2.1kg
(4.6 lbs.)
Dimensions Height: 217 mm
Width: 280 mm
Depth: 46 mm
Display Active Area: 266 mm (10.4")
Resolution: 1024 x 768 LCD
Speaker count 2

The EV1000 clinical platform accessories

EV1000 systemModel number
EV1000 clinical platform EV1000CS
ClearSight Enhanced Software Package SWEV113
SWEV113W7
EV1000 systemModel number
Monitor EV1000M
Monitor Bracket EVMB1
EV1000 Panel Cover EV1000CVR
EV1000 databoxModel number
Databox EV1000DB
Databox Monitor Bracket EVBB1
Transducer Holder EVDTH4
EV1000 pump-unitModel number
Pump-Unit EVPMP
EV1000 noninvasive peripheral hardwareModel number
Pressure controller Kit PC2K
Pressure controller band multi pack PC2B
Pressure controller cuff connector cap PC2CCC
Heart reference sensor EVHRS
ClearSight system enhanced software package

The ClearSight System Enhanced Software Package is included with all new purchases of the EV1000 clinical platform.

ClearSight system

The ClearSight system is a noninvasive solution that offers you proactive decision support to optimize perfusion. The ClearSight finger cuff provides noninvasive access to continuous BP in addition to advanced hemodynamic parameters. Learn more here.

Fluid responsiveness test

With the fluid responsiveness test, you have the ability to assess preload responsiveness by tracking the changes in advanced parameters such as SV, SVI, CO, or CI in response to a fluid challenge. You are able to continuously monitor patient status while conducting a fluid responsiveness test.

Focused monitoring screens

The focused monitoring screens allow you to see arterial blood pressure along with data for up to three selected parameters in a streamlined layout for at-a-glance viewing. The focused screens also display parameters arranged by flow, resistance, preload response or pressure.

Clinical application

See the difference

The EV1000 clinical platform provides the ability to customize and configure the alarms and the targets for each parameter, giving you decision support for individualized patient care.

Advanced hemodynamic parameters can be used in clinical practice to aid in ensuring your patients are adequately perfused as well as managing hemodynamic instability, particularly hypotension. Additionally, advanced hemodynamic parameters help guide fluid administration, so you can maintain patients in their optimal volume range.

Studies show prolonged exposures below mean arterial pressure (MAP) thresholds of 65 mmHG are associated with increased risk of myocardial injury and AKI after noncardiac surgery.

Managing hypotension and differentiating the root cause requires continuous monitoring of both arterial pressure and cardiac output (CO).

  • Perfusion = adequate arterial pressure and cardiac output (CO)
  • Cardiac Output (CO) = Stroke Volume (SV) x Heart Rate

Cardiac output is affected by preload, contractility and afterload. Therefore, to manage hypotension effectively it is necessary to understand address the cause of hemodynamic imbalance.

Stroke volume optimization (SV)

When managing perfusion, stroke volume can be optimized using the patient’s own Frank-Starling curve — a plot of stroke volume (SV) vs. preload.

With the FloTrac or ClearSight sytem, the patient’s location on his or her Frank-Starling curve can be determined by measuring ∆SV in response to change in preload using bolus fluid challenge or passive leg raise.

Stroke volume variation otimization (SVV)

For control-ventilated patients, SVV has proved to be a highly sensitive and specific indicator for pre-load responsiveness, serving as an accurate marker of patient status on the Frank-Starling curve.

Advanced hemodynamic parameters, when implemented within a perioperative goal-directed therapy (PGDT) protocol, are demonstrated to reduce post-surgical complications in moderate to high-risk surgery patients. The FloTrac system provides advanced hemodynamic parameters that can be used in PGDT to control variability in volume administration and help you maintain your patient in the optimal volume range.

Acumen Analytics software

Acumen Analytics software offers you retrospective data analysis and hemodynamic insights into patient perfusion. This software allows clinicians to retrospectively view and analyze monitored hemodynamic parameters from the Acumen IQ sensor, FloTrac sensor, or ClearSight finger cuff.

Compatible products

Based on the complexity of each procedure, and patient risk factors, choose your preferred dynamic and flow-based parameters and the appropriate Edwards' hemodynamic monitoring solution to suit your clinical approach and your moderate to high-risk surgical patients’ needs.

Edwards clinical education

Hemodynamic education empowering clinical advancement

With a long-term commitment to improving the quality of care for surgical and critical care patients through education, Edwards clinical education meets you no matter where you are in the learning process — with a continuum of resources and tools that continuously support you as you solve the clinical challenges facing you today, and in the future.

For more educational information

Contact us

The Edwards advantage

We are committed to providing your institution, clinicians and staff with a high level of customer service and support to ensure seamless product implementation and ongoing use:

  • Technical support – Call +8001 8001 801 or email techserv_europe@edwards.com

Contact a sales representative

Do you have feedback about our products? Click here

References:
  1. Cecconi M, Fasano N, Langiano N, et al. Goal directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia. Crit Care. 2011;15:R132
  2. Sinclair S, James S, Singer M. Intraoperative intravascular volume optimization and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. AMJ. 1997;315:909–912.
  3. Gan T, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97(4):820–826.
  4. Venn R, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88(1):65–71.
  5. Conway D, Mayall R, Abdul-Latif M, Gilligan S, Tackaberry C. Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia. 2002;57(9):845–849.
  6. McKendry M, McGloin H, Saberi D, Caudwell L, Brady A, Singer M. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ. 2004;329:358.
  7. Wakeling H, McFall M, Jenkins C, Woods W, Barclay G, Fleming S. Intraoperative oesophageal Doppler-guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95(5):634–642
  8. Noblett S, Snowden C, Shenton B, Horgan A. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. BJS. 2006;93(9):1069–1076.
  9. ChytraI, Pradl R, Bosman R, Pelnar P, Kasal E, Zidkova A. Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial. Crit Care. 2007;11:R24.
  10. Benes J, ChytraI, Altmann P, et al. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14:1-15.
  11. Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007;132:1817–1824.
  12. Grocott et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane systematic review. Br J Anaesth 2013
  13. Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth 2009; 103: 637–46
  14. Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care 2011; 15: R154
  15. Corcoran T et al. Perioperative Fluid Management Strategies in Major Surgery: A Stratified Meta-Analysis. Anesthesia – Analgesia 2012
  16. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high risk surgical patients. Anesthesia – Analgesia 2011; 112: 1392–402.
  17. Bellamy, MC. Wet, dry or something else? B J Anaestha. 2006; 97(6): 755–757
  18. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8.
  19. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11.
  20. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30.
  21. Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43.
  22. Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91.
  23. Rady, MY, et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14(2):218-25.
  24. Nakazawa, K, et al. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with end-tidal carbon dioxide monitoring. Intensive Care Med 1994;20(6):450-1.
  25. Rivers, EP, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med 1992;21(9):1094-101.
  26. Loren D. Continuous venous oximetry in surgical patients. Ann Surg. 1986;203/3:329-333.
  27. Donati A, et al. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk patients. Chest. 2007;132:1817-1824.
  28. Noguiera P, et al. Central Venous Saturation: A Prognostic Tool in Cardiac Surgery Patients. J Intensive Care Med. 2010;25(2):111-116.
  29. Vallet B, et al. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14:213.
  30. Edwards, Vigileo Operators Manual: A-4.
  31. Pearse, R, et al. Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005;9(6):R694-91.
  32. CL Gurudatt. Perioperative fluid therapy: How much is not too much? Indian J Anaesth. 2012 Jul-Aug: 56(4): 323-®325
  33. Monet et al.  Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS.  Intensive Care Med, 2007;33:448-453

For professional use

For professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Please update your browserClose this window

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility